Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKesson
Baxter
Colorcon
Express Scripts
Medtronic
Merck

Last Updated: November 22, 2019

DrugPatentWatch Database Preview

Litigation Details for LOUISIANA WHOLESALE v. PFIZER, INC. (D.N.J. 2002)

See Plans and Pricing

« Back to Dashboard

LOUISIANA WHOLESALE v. PFIZER, INC. (D.N.J. 2002)

Docket   Start Trial Date Filed 2002-04-18
Court District Court, D. New Jersey Date Terminated 2014-08-06
Cause 15:15 Antitrust Litigation Assigned To Madeline Cox Arleo
Jury Demand Plaintiff Referred To William Clark
Parties LOUISIANA WHOLESALE DRUG COMPANY, INC.; MEIJER DISTRIBUTION, INC.; MEIJER, INC.; PFIZER, INC.; WARNER-LAMBERT CO.
Patents 4,024,175; 4,087,544; 4,894,476; 5,084,479; 6,054,482
Attorneys JOHN J. FRANCIS , JR.; JONATHAN D. CLEMENTE; MICHAEL CHARLES ZOGBY
Firms Clemente Mueller P.A.; Drinker Biddle & Reath LLP
Link to Docket External link to docket
Small Molecule Drugs cited in LOUISIANA WHOLESALE v. PFIZER, INC.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for LOUISIANA WHOLESALE v. PFIZER, INC. (D.N.J. 2002)

Date Filed Document No. Description Snippet Link To Document
2002-04-18 1 Neurontin was protected by two patents; U.S. Patent No. 4,024,175 (“the ‘175 patent”), which claimed the chemical…aforementioned patents, Pfizer owns three other gabapentin-related patents: U.S. Patent No. 4,894,475 …alleged herein, neither the ‘475 patent, nor the ‘479 patent, nor the ‘432 patent satisfies the first requirement…a. that no patent for the brand-name drug has been filed with the FDA; b. that the patent for the brand-name… triggers the time by which a patent owner may file an action for patent infringement, and take advantage External link to document
2009-08-28 42 various patents covering the drug and its uses. Warner-Lambert obtained U.S. Patent No. 4,024,175 (the …resulting patent prosecution. The low-lactam gabapentin patent was ultimately issued as U.S. Patent No. 6,054,482…for issuance as U.S. Patent No. 5,395,852 (the “‘852 Patent”). The ‘852 Patent was scheduled to issue…application, so that the patent examiner could consider the ‘476 Patent as well as U.S. Patent No. 4,152,326 (…to it by a patent or a series of patents. Fraudulently delaying the issuance of a patent could lead External link to document
2009-08-28 44 various patents covering the drug and its uses. Warner-Lambert obtained U.S. Patent No. 4,024,175 (the …resulting patent prosecution. The low-lactam gabapentin patent was ultimately issued as U.S. Patent No. 6,054,482…for issuance as U.S. Patent No. 5,395,852 (the “‘852 Patent”). The ‘852 Patent was scheduled to issue…application, so that the patent examiner could consider the ‘476 Patent as well as U.S. Patent No. 4,152,326 (…to it by a patent or a series of patents. Fraudulently delaying the issuance of a patent could lead External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Merck
Colorcon
Baxter
Harvard Business School
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.